While the daily PM2.5 levels have reduced in Europe and North...
Category:
Health
Latest
H3N2 also spreads like COVID, elderly should be careful: Dr Randeep Guleria
Dr Randeep Guleria "It spreads through droplets. However, I think...
Delhi HC asks consortium for rare diseases to give recommendations on funding of clinical trials
The consortium shall consider the age of children whose lives may...
With very high COVID-19 testing, India’s positivity rate fallen below 8%: MoHFW
“India has exponentially scaled up its testing capacity from one in January to more than 9.32 cr at present. The very high testing has resulted in the continuous falling positivity rate. It has now fallen below 8 per cent,” the Ministry tweeted.
Pan-India Covid-19 genome studies suggest virus genetically stable: PMO
Indrajit Saha, an assistant professor in the Department of Computer Science and Engineering of National Institute of Technical Teachers’ Training and Research, Kolkata, and his team have also developed a web-based Covid-Predictor to predict the sequence of viruses online on the basis of machine learning.
Possibility of second wave of coronavirus infections in winter season cannot be ruled out: Expert panel chief V K Paul
“In India, the new coronavirus cases and number of deaths have declined in the last three weeks and the pandemic has stabilised in most of the statesHowever, there are five states (Kerala, Karnataka, Rajasthan, Chhattisgarh and West Bengal) and 3-4 Union Territories (UTs), where there is still a rising trend,” Paul said.
Coronavirus survives on skin 5 times longer than flu: Study
“The nine-hour survival of SARS-CoV-2 (the virus strain that causes Covid-19) on human skin may increase the risk of contact transmission in comparison with IAV (influenza A virus), thus accelerating the pandemic,” said the study published this month in the Clinical Infectious Diseases journal
Living coronavirus detected, isolated on frozen food packaging in China
The finding was made during an investigation to trace the source of recent infections reported in the city. It has proved that contact with packaging contaminated by living novel coronavirus could lead to infection, state-run Xinhua news agency reported, quoting the CDC statement.
COVID-19 prompts workers, corporates to adopt gig economy
Experts believe that gig economy provides a win-win situation for both parties and its reach is slowly expanding from less-skilled services to high-skilled jobs.
“Gig economy has been there for a long time. It’s being embraced like never before, that too in India, due to both economic conditions and COVID-19 situation,” said Kaushik Banerjee, Vice President and Business Head of Teamlease.com and Freshersworld.com.
Covid-19 pandemic could run its course by Feb: Govt panel
The committee including professors from IITs and IISc besides scientists, said that upcoming festival and winter seasons may increase the susceptibility to the infection but all activities can be resumed provided proper safety protocols are followed.
Air pollution hypertension among top 5 risk factors for death in India in 2019 Study
According to the study, hypertension is the third leading risk factor after air pollution, responsible for 10-20 per cent of all health loss in eight states in India, primarily in the south.
“Most of these risk factors are preventable and treatable, and tackling them will bring huge social and economic benefits,” said study lead author Christopher Murray, Director of the Institute for Health Metrics and Evaluation (IHME) at the University of Washington in the US.
Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon: Vardhan
Vardhan said the late stage trial generally involves thousands of participants, sometimes 30,000 to 40,000.
Of the vaccines currently in Phase 3 trials, all are administered by injection, according to the World Health Organization (WHO).
India begins selecting people for priority coronavirus vaccines
The plan, which is still in the draft stage, aims to cover 23% of the population in the first phase. The final plan is likely to be ready by end October-November, the report said.
The selected individuals will be given an estimated 600 million doses.